| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(96)00317-9 |
| P8608 | Fatcat ID | release_s2fstvi6n5gitei27bp7h5ai4a |
| P698 | PubMed publication ID | 9269058 |
| P2093 | author name string | Leinonen M | |
| Pyhälä R | |||
| Honkanen PO | |||
| Sankilampi U | |||
| P2860 | cites work | Thymus-independent and thymus-dependent responses to polysaccharide antigens | Q28249349 |
| Influenza vaccination in 18 developed countries, 1980-1992. | Q30464520 | ||
| Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. | Q34714546 | ||
| Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial | Q35190152 | ||
| Cross-reactions between pneumococci and other streptococci due to C polysaccharide and F antigen. | Q37220192 | ||
| Adverse reactions to polyvalent pneumococcal vaccine | Q40847841 | ||
| HA1 domain of influenza A (H3N2) viruses in Finland in 1989-1995: evolution, egg-adaptation and relationship to vaccine strains | Q41252059 | ||
| Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial | Q43453539 | ||
| Antibody to Capsular Polysaccharides of Streptococcus pneumoniae: Prevalence, Persistence, and Response to Revaccination | Q57250794 | ||
| Vaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic drift | Q57303234 | ||
| Immunogenicity of pneumococcal revaccination in patients with chronic disease | Q64135288 | ||
| Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination | Q69162258 | ||
| Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers | Q70545771 | ||
| Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly | Q70916641 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza vaccine | Q383260 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 1133-1137 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly | |
| P478 | volume | 15 |
| Q40447224 | Adverse events after pneumococcal vaccination. |
| Q51752825 | Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults. |
| Q34744239 | Current state of pneumococcal vaccines |
| Q39374927 | Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies |
| Q36255837 | Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults |
| Q34926870 | Pneumococcal Vaccination and Revaccination of Older Adults |
| Q34273624 | Pneumococcal disease in the elderly: what is preventing vaccine efficacy? |
| Q38006281 | Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults |
| Q33844529 | Prevention of pneumococcal disease: an update on the Belgian Consensus Report |
| Q40528481 | Reactions after pneumococcal vaccine alone or in combination with influenza vaccine |
| Q47398807 | Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia |
| Q74458958 | Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors |
| Q34218669 | The prevention of pneumococcal disease by vaccines: promises and challenges |
| Q73563103 | Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults |
Search more.